Task: Answer the MCQ question.
Question: Which drug exhibits a 2.858% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. CCCSc1nc(O)c(C(c2ccc(OC)c(O)c2)c2c(O)nc(SCCC)n(C)c2=O)c(=O)n1C
b. CC(C)N(C(=O)CSc1nc(Cc2ccccc2)nc2ccccc12)C(C)C
Answer: b. CC(C)N(C(=O)CSc1nc(Cc2ccccc2)nc2ccccc12)C(C)C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)N(C(=O)CSc1nc(Cc2ccccc2)nc2ccccc12)C(C)C
CC(C)N(C(=O)CSc1nc(Cc2ccccc2)nc2ccccc12)C(C)C
2-(2-benzylquinazolin-4-yl)sulfanyl-N,N-di(propan-2-yl)acetamide